Chronic Hand Dermatitis — Apremilast and Moderate to Severe Chronic Hand Dermatitis
Citation(s)
An Open-label, Single-Arm Pilot Study Investigating the Efficacy and Safety of Apremilast for the Treatment of Moderate to Severe Chronic Hand Dermatitis